Assessment of Surgically Removed Abdominal Wall Endometriomas
Clinico-pathological Assessment of Surgically Removed Abdominal Wall Endometriomas
1 other identifier
observational
30
1 country
1
Brief Summary
A retrospective review of all patients who underwent surgery for an anterior abdominal wall mass which confirmed by pathology examination as an endometrioma will be completely performed. The clinical data will be recorded and pathology report diagnosis will be correlated with the clinical data to assess the possible causes of endometrioma in the women treated in our tertiary hospital and the efficacy of the surgical excision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 17, 2020
CompletedFirst Submitted
Initial submission to the registry
November 17, 2020
CompletedFirst Posted
Study publicly available on registry
November 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2020
CompletedMarch 10, 2021
March 1, 2021
2 months
November 17, 2020
March 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Positive for endometrioma
Presence of endometrial glands and stroma along with hemosidren pigment under microscopic examination, confirms the diagnosis and the case will be calculated and the related clinical data
1 day
Study Arms (2)
Cesarean sectioned
All females who treated in our hospital by Cesarean section operation during two-years-period
Complicated with Abdominal wall endometriosis
All the surgically excised endometrioma cases during the same time period
Interventions
Reexamination of the stained slides of the patients from the hospital archive and adding a CD10 stain when required
Eligibility Criteria
Female patients treated in our hospital and pathologically examined in our hospital
You may qualify if:
- Female
- Surgically removed abdominal wall endometrioma
You may not qualify if:
- Male (very very rare to occur)
- medically treated enodmetrioma
- Outside treated patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abdulkarim Hasan
Cairo, 11884, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Abdulkarim Hasan, MD
Al-Azhar University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pathologist and Laboratory Director
Study Record Dates
First Submitted
November 17, 2020
First Posted
November 20, 2020
Study Start
October 17, 2020
Primary Completion
December 15, 2020
Study Completion
December 20, 2020
Last Updated
March 10, 2021
Record last verified: 2021-03